HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adelaide Fernandes Selected Research

Hyperbilirubinemia

2/2015Bilirubin-induced neural impairment: a special focus on myelination, age-related windows of susceptibility and associated co-morbidities.
1/2009Contribution of inflammatory processes to nerve cell toxicity by bilirubin and efficacy of potential therapeutic agents.
5/2007Influence of hypoxia and ischemia preconditioning on bilirubin damage to astrocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Adelaide Fernandes Research Topics

Disease

18Inflammation (Inflammations)
01/2023 - 07/2006
9Brain Diseases (Brain Disorder)
01/2015 - 08/2004
6Alzheimer Disease (Alzheimer's Disease)
10/2022 - 01/2015
6Kernicterus
01/2016 - 09/2007
5Multiple Sclerosis
01/2022 - 01/2016
5Necrosis
07/2014 - 03/2006
4Demyelinating Diseases (Demyelinating Disease)
11/2021 - 01/2016
4Gliosis
01/2020 - 02/2014
3Cognitive Dysfunction
01/2023 - 01/2017
3Neuroinflammatory Diseases
01/2022 - 01/2015
3Neoplasms (Cancer)
01/2022 - 01/2017
3Hyperbilirubinemia
02/2015 - 05/2007
3Sepsis (Septicemia)
02/2015 - 08/2004
2Atrophy
01/2023 - 07/2014
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022 - 01/2020
2Colitis
06/2019 - 01/2017
2Frailty
01/2019 - 11/2018
2Neurologic Manifestations (Neurological Manifestations)
01/2016 - 02/2015
2Wounds and Injuries (Trauma)
05/2015 - 12/2012
2Ischemia
04/2015 - 05/2007
2Hypoxia (Hypoxemia)
02/2015 - 05/2007
2Neonatal Hyperbilirubinemia
05/2007 - 02/2007
1Encephalitis (Encephalitis, Rasmussen)
01/2023
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2022
1Pathologic Processes
07/2021
1Body Weight (Weight, Body)
04/2021
1Disease Progression
08/2020
1Paralysis (Palsy)
01/2020
1Memory Disorders (Memory Loss)
01/2020
1Fibrosis (Cirrhosis)
11/2018
1Melanoma (Melanoma, Malignant)
11/2018

Drug/Important Bio-Agent (IBA)

17BilirubinIBA
01/2016 - 11/2005
9CytokinesIBA
01/2020 - 08/2004
6MicroRNAs (MicroRNA)IBA
10/2022 - 01/2015
6Biomarkers (Surrogate Marker)IBA
07/2021 - 01/2015
3Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2012
3CarrageenanIBA
06/2019 - 05/2015
3Interleukin-6 (Interleukin 6)IBA
11/2018 - 02/2007
3NF-kappa B (NF-kB)IBA
02/2018 - 03/2006
3glycoursodeoxycholic acidIBA
07/2014 - 09/2007
3Glutamic Acid (Glutamate)FDA Link
06/2012 - 07/2006
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2007 - 03/2006
2Insulin (Novolin)FDA Link
01/2023 - 04/2015
2Hormones (Hormone)IBA
01/2023 - 11/2018
2LeptinIBA
01/2023 - 11/2018
2LigandsIBA
01/2022 - 11/2018
2Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
01/2020 - 01/2016
2InflammasomesIBA
05/2018 - 01/2016
2Peptides (Polypeptides)IBA
01/2017 - 07/2015
2Amyloid (Amyloid Fibrils)IBA
01/2017 - 07/2015
2Glucose (Dextrose)FDA LinkGeneric
12/2012 - 05/2007
2InterleukinsIBA
12/2010 - 09/2007
1Pentamidine (NebuPent)FDA LinkGeneric
01/2022
1Programmed Cell Death 1 ReceptorIBA
01/2022
1Coloring Agents (Dyes)IBA
11/2021
1LipidsIBA
11/2021
1Boronic AcidsIBA
11/2021
1Anti-Anxiety Agents (Anxiolytics)IBA
04/2021
1Receptor for Advanced Glycation End ProductsIBA
01/2020
1Dimethyl FumarateIBA
01/2020
1AntioxidantsIBA
01/2020
1FPS-ZM1IBA
01/2020
1SenotherapeuticsIBA
01/2019
1Glycoproteins (Glycoprotein)IBA
11/2018
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
11/2018
1Plasminogen Activator Inhibitor 1IBA
11/2018
1lactate dehydrogenase 3IBA
11/2018
1fibroblast growth factor 21IBA
11/2018
1ProgranulinsIBA
11/2018
1Fibroblast Growth Factor-23IBA
11/2018
1Protein Glutamine gamma Glutamyltransferase 2IBA
11/2018
1Insulin-Like PeptidesIBA
11/2018
1AngiotensinogenIBA
11/2018
1Growth Differentiation Factor 15IBA
11/2018
1GhrelinIBA
11/2018
1Keratin-18 (Keratin 18)IBA
11/2018
1ResistinIBA
11/2018
1CalciumIBA
11/2018
1Calcium-Binding ProteinsIBA
11/2018
1AdiponectinIBA
11/2018
1IgA receptor (protein B)IBA
11/2018
1AdenosylhomocysteinaseIBA
11/2018
1CalreticulinIBA
11/2018
1Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA
11/2018
1HMGB1 Protein (HMG1)IBA
11/2018
1DefensinsIBA
11/2018
1Insulin-Like Growth Factor I (IGF-1)IBA
11/2018
1LactoferrinIBA
11/2018
1Brain-Derived Neurotrophic Factor (BDNF)IBA
11/2018
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
11/2018
1ChemokinesIBA
11/2018
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
11/2018
1Plasminogen Activators (Plasminogen Activator)IBA
11/2018
1AgrinIBA
11/2018
1RNA (Ribonucleic Acid)IBA
11/2018
1Growth Hormone (Somatotropin)IBA
11/2018
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/2018

Therapy/Procedure

5Therapeutics
01/2023 - 06/2012
1Immunotherapy
01/2022
1Immunomodulation
08/2020